Increased nitric oxide in exhaled air in patients with systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 16, Issue 5, 1998, Pages 547-552

  Fajac, I ^a   Kahan, A ^b   Menkes C J ^b   Dessanges, J F ^a   Dall'Ava Santucci, J ^a   Dinh Xuan, A T ^a  

^a Department of Respiratory Physiology ^*

^b Univ of Paris V Rene Descartes ^*  (France)

Author keywords

Nitric oxide; Pulmonary; Scleroderma

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME INDUCTION; EXPIRED AIR; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG DISEASE; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; BREATH TESTS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC;

EID: 0031708120     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BOLSTER MB, SILVER RM: Lung disease in systemic sclerosis (scleroderma). Clin Rheumatol 1993; 7: 79-97.
2. BREIT SN, THORNTON SC, PENNY R: Lung involvement in scleroderma. Clin Dermatol 1994; 12: 243-52.
3. UNGERER RG, TASHKIN DP, FURST D, et al.: Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75: 65-74.
4. STUPI AM, STEEN VD, OWENS GR, BARNES LE, RODNAN GP, MEDSGER TAJ: Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-24.
5. MONCADA S, HIGGS EA: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
6. BARNES PJ, BELVISI MG: Nitric oxide and lung disease. Thorax 1993; 48: 1034-43.
7. PEPKE-ZABA J, HIGENBOTTAM TW, DINH-XUAN AT, STONE D, WALLWORK J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338: 1173-4.
8. DINH-XUAN AT, HIGENBOTTAM TW, CLELLAND CA, et al.: Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 1991; 324: 1539-47.
9. DINH-XUAN AT: Disorders of endothelium-dependent relaxation in pulmonary disease. Circulation 1993; 87 (Suppl. V): V81-7.
10. GIAID AG, SALEH D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-21.
11. MATUCCI-CERINIC M, PIETRINI U, MARABINI S: Local venomotor response to intravenous infusion of substance P and glyceryl trinitrate in systemic sclerosis. Clin Exp Rheumatol 1990; 8: 561-5
12. KHARITONOV SA, CAILES JB, BLACK CM, DU BOIS RM, BARNES PJ: Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997; 52: 1051-5.
13. ALVING K, WEITZBERG E, LUNDBERG JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur J Respir 1993; 6: 1368-70.
14. STEWART TE, VALENZA F, RIBEIRO SP, et al.: Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995; 151: 713-8.
15. MURRELL DF: A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 1993; 28: 78-85.
16. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE ARA DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
17. LEROY EC, BLACK C, FLEISCHMAJER R, et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
18. PERSSON MG, WIKLUND NP, GUSTAFSSON LA: Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 1993; 148: 1210-4.
19. SAIR M, EVANS TW: NO news is good news. Thorax 1995; 50: 323-4.
20. SILVER RM, MILLER KS, KINSELLA MB, SMITH EA, SCHABEL SI: Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990; 88: 470-6.
21. BECKMAN JS, BECKMAN TW, CHEN J, MARSHALL PA, FREEMAN BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
22. BRATT J, GYLLENHAMMAR H: The role of nitric oxide in lipoxin A4-induced polymorphonuclar neutrophil-dependent cytotoxicity to human vascular endothelium in vitro. Arthritis Rheum 1995; 38: 768-76.
23. GARNIER P, FAJAC I, DESSANGES JF, DALL'AVA-SANTUCCI J, LOCKHART A, DINH-XUAN AT: Exhaled nitric oxide during acute changes of airways calibre in asthma. Eur Respir J 1996; 9: 1134-8.
24. KHARITONOV SA, WELLS A, O'CONNOR B, et al.: Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1889-93.
25. LUNDBERG JON, WEITZBERG E, LUNDBERG JM, ALVING K: Intragastric nitric oxide production in humans: Measurements in expelled air. Gut 1994; 35: 1543-6.
26. RADOMSKI M, PALMER R, MONCADA S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-9.
27. AEBERHARD EE, HENDERSON SA, ARABOLOS NS, et al.: Nonsteroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995; 208: 1053-9.
28. LÜSCHER TF, YANG Z: Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 1993; 46 (Suppl. 2): 121-32.
29. VANHOUTTE PM, BOULANGER CM, ILLIANO SC, NAGAO T, VIDAL M, MOMBOULI JV: Endothelium-dependent effects of converting enzyme inhibitors. J Cardiovasc Pharmacol 1993; 22 (Suppl. 5): S10-6.
30. SZABO C, THIEMERMANN C, VANE JR: Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun 1993; 196: 825-30.
31. BAUDOUIN SV, BATH P, MARTIN JF, DU BOIS R, EVANS TW: L-arginine infusion has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br J Clin Pharmacol 1993; 36: 45-9.